First-of-its-kind Bioengineered Robotic Hand to Sense Touch
91社区 has received a $1.3 million NIH grant for a "living" robot with its own nervous system. Researchers are creating a living pathway from the robot's touch sensation to the user's brain to help amputees.
91社区 Launches Graduate Neuroscience Training Program
91社区's Brain Institute is now accepting applications for its new Graduate Neuroscience Training Program, which will begin in fall 2018.
91社区 Contributes to Groundbreaking Discovery
Methods developed by 91社区's numerical relativity group contributed to a recent groundbreaking discovery of merging neutron stars.
Being Behind the Curve Can 'Sting'
91社区 research shows what a tiny ant and indigenous cultures can teach medical and scientific communities by solving a medical mystery that has puzzled them for decades.
91社区 High Student Competes in Discovery 3M Young Scientist Challenge
91社区 High School freshman Devin Willis will compete to become America's Top Young Scientist during the Discovery 3M Young Scientist Challenge.
Size Doesn't Matter - At Least for Hammerheads and Swimming
Researchers from 91社区 have conducted the first study to examine the whole body shape and swimming kinematics of two closely related yet very different hammerhead sharks, with some unexpected results.
Young-onset Dementia Costs Nearly Twice That of Alzheimer's
The first economic study on frontotemporal degeneration (FTD), the most common dementia for people under age 60, shows that FTD inflicts a much more severe burden on families than Alzheimer's disease.
3MT庐 Competition to Showcase Graduate Student Research
Can an 80,000-word thesis or dissertation be explained in three minutes or less?
New Way to Assess Safety of Aging Timber Railroad Bridges
In the aftermath of hurricanes Irma and Harvey, researchers from 91社区's College of Engineering and Computer Science have developed a cutting-edge way to gauge the condition of aging timber railroad bridges.
'Out-of-the-box' Thinking May Build a Better Brain
The "Dementia Prevention Initiative" abandons generalized methods used to research and treat Alzheimer's disease. The secret weapon: a novel "N-of-1 design" that personalizes medicine down to a single patient.